• Insmed EPS for the quarter ending March 31, 2025 was $-1.42, a 33.96% increase year-over-year.
• Insmed 2024 annual EPS was $-5.57, a 4.31% increase from 2023.
• Insmed 2023 annual EPS was $-5.34, a 36.57% increase from 2022.
• Insmed 2022 annual EPS was $-3.91, a 0.77% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.